Oireachtas Joint and Select Committees

Wednesday, 12 July 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion

9:00 am

Mr. Shaun Flanagan:

It is a statement of fact - the NCPE website report is there - that Entresto is on the NCPE website as meeting the cost-effectiveness test, if one accepts that the cost-effectiveness test has a result of €45,000 per quality-adjusted life year. If that is the Deputy's definition of cost effectiveness, it is cost-effective.